Highly immunosuppressive myeloid cells correlate with early relapse after allogeneic stem cell transplantation
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Highly immunosuppressive myeloid cells correlate with early relapse after allogeneic stem cell transplantation ; volume:13 ; number:1 ; day:11 ; month:5 ; year:2024 ; pages:1-6 ; date:12.2024
Experimental hematology & oncology ; 13, Heft 1 (11.5.2024), 1-6, 12.2024
- Creator
-
Notarantonio, Anne-Béatrice
Bertrand, Allan
Piucco, Romain
Fievet, Ghislain
Sartelet, Hervé
Boulangé, Laura
Isla, Natalia de
Carvalho Bittencourt, Marcelo De
Hergalant, Sébastien
Rubio, Marie-Thérèse
D’Aveni, Maud
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s40164-024-00516-4
- URN
-
urn:nbn:de:101:1-2407221025535.893361858775
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:54 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Notarantonio, Anne-Béatrice
- Bertrand, Allan
- Piucco, Romain
- Fievet, Ghislain
- Sartelet, Hervé
- Boulangé, Laura
- Isla, Natalia de
- Carvalho Bittencourt, Marcelo De
- Hergalant, Sébastien
- Rubio, Marie-Thérèse
- D’Aveni, Maud
- SpringerLink (Online service)
Other Objects (12)
Blinatumomab for Acute Lymphoblastic Leukemia Relapse after Allogeneic Hematopoietic Stem Cell Transplantation
Genomic prediction of relapse in recipients of allogeneic haematopoietic stem cell transplantation
Outcomes following second allogeneic stem cell transplant for disease relapse after T cell depleted transplant correlate with remission status and remission duration after the first transplant
Intrathecal CAR-NK cells infusion for isolated CNS relapse after allogeneic stem cell transplantation: case report
The role of immune checkpoint molecules for relapse after allogeneic hematopoietic cell transplantation
Proteomics to predict relapse in patients with myelodysplastic neoplasms undergoing allogeneic hematopoietic cell transplantation
FLT3-inhibitor therapy for prevention and treatment of relapse after allogeneic hematopoietic cell transplantation
FLT3-inhibitor therapy for prevention and treatment of relapse after allogeneic hematopoietic cell transplantation
Combination of Donor Lymphocyte Infusion and Blinatumomab for B-Cell Lymphoblastic Lymphoma Relapse after Allogeneic Stem-Cell Transplantation
Correlation of nutrition-associated parameters with non-relapse mortality in allogeneic hematopoietic stem cell transplantation
Isolated central nervous system relapse of chronic myeloid leukemia after allogeneic hematopoietic stem cell transplantation
Non-traditional CD4+CD25−CD69+ regulatory T cells are correlated to leukemia relapse after allogeneic hematopoietic stem cell transplantation
Blinatumomab for Acute Lymphoblastic Leukemia Relapse after Allogeneic Hematopoietic Stem Cell Transplantation
Genomic prediction of relapse in recipients of allogeneic haematopoietic stem cell transplantation
Outcomes following second allogeneic stem cell transplant for disease relapse after T cell depleted transplant correlate with remission status and remission duration after the first transplant
Intrathecal CAR-NK cells infusion for isolated CNS relapse after allogeneic stem cell transplantation: case report
The role of immune checkpoint molecules for relapse after allogeneic hematopoietic cell transplantation
Proteomics to predict relapse in patients with myelodysplastic neoplasms undergoing allogeneic hematopoietic cell transplantation
FLT3-inhibitor therapy for prevention and treatment of relapse after allogeneic hematopoietic cell transplantation
FLT3-inhibitor therapy for prevention and treatment of relapse after allogeneic hematopoietic cell transplantation
Combination of Donor Lymphocyte Infusion and Blinatumomab for B-Cell Lymphoblastic Lymphoma Relapse after Allogeneic Stem-Cell Transplantation
Correlation of nutrition-associated parameters with non-relapse mortality in allogeneic hematopoietic stem cell transplantation
Isolated central nervous system relapse of chronic myeloid leukemia after allogeneic hematopoietic stem cell transplantation
Non-traditional CD4+CD25−CD69+ regulatory T cells are correlated to leukemia relapse after allogeneic hematopoietic stem cell transplantation
Blinatumomab for Acute Lymphoblastic Leukemia Relapse after Allogeneic Hematopoietic Stem Cell Transplantation
Genomic prediction of relapse in recipients of allogeneic haematopoietic stem cell transplantation
Outcomes following second allogeneic stem cell transplant for disease relapse after T cell depleted transplant correlate with remission status and remission duration after the first transplant
Intrathecal CAR-NK cells infusion for isolated CNS relapse after allogeneic stem cell transplantation: case report
The role of immune checkpoint molecules for relapse after allogeneic hematopoietic cell transplantation
Proteomics to predict relapse in patients with myelodysplastic neoplasms undergoing allogeneic hematopoietic cell transplantation
FLT3-inhibitor therapy for prevention and treatment of relapse after allogeneic hematopoietic cell transplantation
FLT3-inhibitor therapy for prevention and treatment of relapse after allogeneic hematopoietic cell transplantation
Combination of Donor Lymphocyte Infusion and Blinatumomab for B-Cell Lymphoblastic Lymphoma Relapse after Allogeneic Stem-Cell Transplantation
Correlation of nutrition-associated parameters with non-relapse mortality in allogeneic hematopoietic stem cell transplantation
Isolated central nervous system relapse of chronic myeloid leukemia after allogeneic hematopoietic stem cell transplantation